FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009702902> ?p ?o ?g. }

• W2009702902 abstract "Abstract Context Effective symptom reduction has the potential to significantly improve health-related quality of life (HRQoL) in patients with overactive bladder (OAB), particularly those experiencing urgency urinary incontinence (UUI). Objective To assess the evidence for flexible therapy with fesoterodine for patients with OAB, focussing on UUI. Evidence acquisition A nonsystematic search performed in 2010 was used to identify relevant literature regarding fesoterodine therapy. Evidence synthesis Antimuscarinic medications are the first-line pharmacotherapy for OAB, and tolterodine has been the treatment of choice for many patients. However, optimal efficacy may be difficult to achieve because of tolterodine's limited dosing options. Fesoterodine, a nonselective oral antimuscarinic with the same active metabolite as tolterodine, provides an alternative option. After oral administration, fesoterodine is rapidly and extensively converted into 5-hydroxymethyl tolterodine by ubiquitous, nonspecific plasma esterases, thus bypassing the hepatic cytochrome P450 pathway that mediates the metabolism of tolterodine. The superiority of fesoterodine 8mg over tolterodine extended release (ER) 4mg for the effective relief of UUI episodes and other OAB symptoms and improvements in HRQoL has been demonstrated in two superiority-design, head-to-head, randomised, placebo-controlled, clinical trials in patients with OAB and UUI. The majority of patients achieved dryness with fesoterodine 8mg, a significantly higher percentage than with tolterodine ER 4mg. Clear dose-response relationships have been defined for fesoterodine in OAB patients for many outcomes, including UUI episodes, mean voided volume, continent days per week and self-reported treatment response. The dose-response magnitude for improving UUI episodes was larger in patients with greater UUI severity. Flexible dosing with fesoterodine appears to be well tolerated, with no unexpected safety signals during long-term treatment and high rates of patient-reported treatment satisfaction. Conclusions Flexible dosing with fesoterodine 4mg and 8mg allows for maximisation of treatment efficacy for a broad spectrum of patients with OAB." @default.
• W2009702902 created "2016-06-24" @default.
• W2009702902 creator A5031133453 @default.
• W2009702902 date "2011-03-01" @default.
• W2009702902 modified "2023-09-26" @default.
• W2009702902 title "Fesoterodine: Individualised Treatment of Urgency Urinary Incontinence Across Patient Groups" @default.
• W2009702902 cites W132581085 @default.
• W2009702902 cites W1481796766 @default.
• W2009702902 cites W1487366477 @default.
• W2009702902 cites W1531562711 @default.
• W2009702902 cites W1602886608 @default.
• W2009702902 cites W1834240270 @default.
• W2009702902 cites W1878280580 @default.
• W2009702902 cites W1958971206 @default.
• W2009702902 cites W1963337052 @default.
• W2009702902 cites W1967312126 @default.
• W2009702902 cites W1967347194 @default.
• W2009702902 cites W1968865622 @default.
• W2009702902 cites W1972477468 @default.
• W2009702902 cites W1973028982 @default.
• W2009702902 cites W1982198273 @default.
• W2009702902 cites W1986753920 @default.
• W2009702902 cites W1987111921 @default.
• W2009702902 cites W1994944862 @default.
• W2009702902 cites W2002743872 @default.
• W2009702902 cites W2014737244 @default.
• W2009702902 cites W2020736125 @default.
• W2009702902 cites W2024627109 @default.
• W2009702902 cites W2037706235 @default.
• W2009702902 cites W2041666025 @default.
• W2009702902 cites W2050350410 @default.
• W2009702902 cites W2053305679 @default.
• W2009702902 cites W2063768742 @default.
• W2009702902 cites W2067889220 @default.
• W2009702902 cites W2071231390 @default.
• W2009702902 cites W2094970779 @default.
• W2009702902 cites W2102524054 @default.
• W2009702902 cites W2103502171 @default.
• W2009702902 cites W2109129247 @default.
• W2009702902 cites W2119098706 @default.
• W2009702902 cites W2131173377 @default.
• W2009702902 cites W2131770336 @default.
• W2009702902 cites W2142469925 @default.
• W2009702902 cites W2169965447 @default.
• W2009702902 cites W2184667274 @default.
• W2009702902 cites W2314251966 @default.
• W2009702902 cites W2323322406 @default.
• W2009702902 cites W2323780377 @default.
• W2009702902 cites W2327894593 @default.
• W2009702902 cites W2508179447 @default.
• W2009702902 doi "https://doi.org/10.1016/j.eursup.2011.01.003" @default.
• W2009702902 hasPublicationYear "2011" @default.
• W2009702902 type Work @default.
• W2009702902 sameAs 2009702902 @default.
• W2009702902 citedByCount "6" @default.
• W2009702902 countsByYear W20097029022013 @default.
• W2009702902 countsByYear W20097029022014 @default.
• W2009702902 countsByYear W20097029022015 @default.
• W2009702902 countsByYear W20097029022016 @default.
• W2009702902 countsByYear W20097029022019 @default.
• W2009702902 crossrefType "journal-article" @default.
• W2009702902 hasAuthorship W2009702902A5031133453 @default.
• W2009702902 hasConcept C126322002 @default.
• W2009702902 hasConcept C126894567 @default.
• W2009702902 hasConcept C142724271 @default.
• W2009702902 hasConcept C151730666 @default.
• W2009702902 hasConcept C204787440 @default.
• W2009702902 hasConcept C2777844464 @default.
• W2009702902 hasConcept C2778531004 @default.
• W2009702902 hasConcept C2778941218 @default.
• W2009702902 hasConcept C2779343474 @default.
• W2009702902 hasConcept C2781020410 @default.
• W2009702902 hasConcept C71924100 @default.
• W2009702902 hasConcept C86803240 @default.
• W2009702902 hasConceptScore W2009702902C126322002 @default.
• W2009702902 hasConceptScore W2009702902C126894567 @default.
• W2009702902 hasConceptScore W2009702902C142724271 @default.
• W2009702902 hasConceptScore W2009702902C151730666 @default.
• W2009702902 hasConceptScore W2009702902C204787440 @default.
• W2009702902 hasConceptScore W2009702902C2777844464 @default.
• W2009702902 hasConceptScore W2009702902C2778531004 @default.
• W2009702902 hasConceptScore W2009702902C2778941218 @default.
• W2009702902 hasConceptScore W2009702902C2779343474 @default.
• W2009702902 hasConceptScore W2009702902C2781020410 @default.
• W2009702902 hasConceptScore W2009702902C71924100 @default.
• W2009702902 hasConceptScore W2009702902C86803240 @default.
• W2009702902 hasLocation W20097029021 @default.
• W2009702902 hasOpenAccess W2009702902 @default.
• W2009702902 hasPrimaryLocation W20097029021 @default.
• W2009702902 hasRelatedWork W1983347072 @default.
• W2009702902 hasRelatedWork W1999745497 @default.
• W2009702902 hasRelatedWork W2005945677 @default.
• W2009702902 hasRelatedWork W2016354109 @default.
• W2009702902 hasRelatedWork W2045054254 @default.
• W2009702902 hasRelatedWork W2096154699 @default.
• W2009702902 hasRelatedWork W2118639686 @default.
• W2009702902 hasRelatedWork W2140008227 @default.
• W2009702902 hasRelatedWork W2150100216 @default.
• W2009702902 hasRelatedWork W2150578431 @default.
• W2009702902 hasRelatedWork W2172498450 @default.

• next